Clinical Trial Update: Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating teneligliptin for progressive left ventricular diastolic dysfunction in type 2 diabetes mellitus patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Diastolic Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Teneligliptin (Teneligliptin)

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN